openPR Logo
Press release

North America Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market to hit US$ 17.15 billion by 2033

11-10-2025 12:17 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

North America Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market

North America Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market

North America metabolic dysfunction-associated steatohepatitis (MASH) treatment market size reached US$ 3.70 billion in 2024 and is expected to reach US$ 17.15 billion by 2033, growing at a CAGR of 19.3% during the forecast period 2025-2033.

DataM Intelligence has released its latest report on the "North America Metabolic Dysfinction Associates Steatohepatitis Mash Treatment Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/north-america-metabolic-dysfunction-associated-steatohepatitis-treatment-market?kb

Latest M&A

Novo Nordisk's $5.2 billion acquisition of Akero Therapeutics (2025) expanded its metabolic disease portfolio with Akero's late-stage FGF21 analog efruxifermin targeting MASH and liver fibrosis, solidifying its U.S. presence as a leader in metabolic therapeutics.​

Roche's deal to acquire 89bio brought additional pipeline assets for MASH treatment in North America, boosting presence in liver disease R&D and advanced therapies.​

Other emerging biotech acquisitions include companies with novel thyroid hormone receptor beta agonists and fibrosis-targeting assets aiming to address chronic liver diseases.

Key Player:

Novo Nordisk A/S, Boehringer Ingelheim International GmbH, 89bio, Inc., Inventiva, Sagimet Biosciences, and Akero Therapeutics, Inc.

Latest News & Pipeline Developments

The FDA approved semaglutide (Wegovy) in 2025 for treatment of non-cirrhotic MASH with stage 2 or 3 fibrosis based on ESSENCE trial data, supporting improved liver function and fibrosis regression in the U.S. market.​

Early real-world data suggests semaglutide reduces MASH progression and need for liver transplants.​

Additional promising candidates in North America include resmetirom (Rezdiffera) by Madrigal Pharmaceuticals, approved for MASH, and evoltrasiran (Alnylam) targeting liver fibrosis in late clinical trials.​

Multiple trials for combination therapies involving PPAR agonists, FXR agonists, and FGF21 analogs are ongoing in the U.S.

Forecast Projection:

The global North America Metabolic Dysfinction Associates Steatohepatitis Mash Treatment market is set to witness strong growth from 2025 to 2032. After maintaining steady momentum in 2024, the market is expected to accelerate as key industry players implement strategic initiatives to boost adoption. Companies that adapt to these emerging trends will be well-positioned to capture new opportunities and enhance their revenue potential throughout the forecast period.

Market Intelligence Research Process:

The North America Metabolic Dysfinction Associates Steatohepatitis Mash Treatment Market Report by DataM Intelligence offers a comprehensive analysis built on a mix of primary and secondary research. It explores key factors driving the industry, including government policies, market trends, competitive landscape, technological advancements, and upcoming innovations. This in-depth study uncovers both growth opportunities and potential challenges, helping businesses navigate market fluctuations and make data-driven decisions for sustainable success.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/download-sample/north-america-metabolic-dysfunction-associated-steatohepatitis-treatment-market?kb

Key Segmentations:

By Stage: (Stage 4, Stage 2-3, Stage 0-1)

By Age Group: (Geriatrics, Adults, Pediatrics)

By Gender: (Male, Female)

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/north-america-metabolic-dysfinction-associates-steatohepatitis-mash-treatment-market?kb

FAQ's

Q1: How large is the North America Metabolic Dysfinction Associates Steatohepatitis Mash Treatment Market?

Ans: The North America Metabolic Dysfinction Associates Steatohepatitis Mash Treatment Market size was valued at US$ 3.70 billion in 2024 and is projected to grow to US$ 17.15 billion by 2033

Q2: How quickly is the North America Metabolic Dysfinction Associates Steatohepatitis Mash Treatment Market expanding?

Ans: The North America Metabolic Dysfinction Associates Steatohepatitis Mash Treatment Market is forecasted to grow at a CAGR of 17.15 % between 2025 and 2032, showing Annual growth momentum

FDA Approvals and Guidance

FDA approval for semaglutide specifically for MASH marks a milestone for treating metabolic liver disease in early stages.​

FDA supports accelerated approval pathways using biomarkers and histological surrogates for MASH drug approvals, expediting North American commercialization.​

Updated U.S. clinical guidelines emphasize early diagnosis and integrated management with pharmacologic and lifestyle approaches in MASH patients.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/north-america-metabolic-dysfunction-associated-steatohepatitis-treatment-market?kb

Reimbursement Trends in North America

Medicare and private health insurers have expanded reimbursement coverage for FDA-approved MASH drugs, including semaglutide and resmetirom, facilitating broad patient access via specialty pharmacies.​

Value-based contracting and real-world evidence programs encourage payers to support therapies that demonstrate slowed disease progression and reduced hospitalization costs.​

Pricing negotiations focus on balancing innovation reimbursement with budget impact given the high prevalence of fatty liver disease in U.S. populations.

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
Linkedin: https://www.linkedin.com/company/datam-intelligence/
Twitter: https://x.com/DataM_Research

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market to hit US$ 17.15 billion by 2033 here

News-ID: 4261736 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Europe E-Commerce Packaging Market Growth Forecast 2024-2031: Market to Surge to USD 108.7 Billion Driven by Sustainability and Innovation
Europe E-Commerce Packaging Market Growth Forecast 2024-2031: Market to Surge to …
The Europe E-Commerce Packaging Market generated revenue of US$16,686 million in 2023 and is forecast to reach US$40,195 million by 2030, growing at a CAGR of 13.4% over the period 2024-2030. The region accounted for approximately 21.3% of the global e-commerce packaging market in 2023, underlining its strategic importance in the global value chain. Fueled by a surge in online retail sales and rising consumer expectations for fast, protective, and sustainable
Singapore probiotic food supplement market is to reach a value of US$ 23.33 million- Driven by Personalized Health Solutions and E-commerce Growth | Exclusive report by DataM Intelligence
Singapore probiotic food supplement market is to reach a value of US$ 23.33 mill …
According to DataM Intelligence,The Singapore probiotic food supplement market recorded a value of US$ 17.02 million in 2023 and is expected to reach a value of US$ 23.33 million in 2027, growing at a CAGR of 8.22% during the forecast period (2024-2027). The growing awareness of gut health, digestive wellness, and immune support is driving demand for probiotic food supplements in Singapore. Rising consumer preference for functional foods, coupled with
United States Anti-Obesity Drugs Market Sector 2025: Pfizer's acquire $10B Metsera Tug of War & Novo Nordisk's Akero Acquisition
United States Anti-Obesity Drugs Market Sector 2025: Pfizer's acquire $10B Metse …
Global Anti-Obesity Drugs Market reached US$ 2.5 billion in 2022 and is expected to reach US$ 43.7 billion by 2030 growing with a CAGR of 45.5% during the forecast period 2024-2031. DataM Intelligence has released its latest report on the "Anti-obesity Drugs Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and
Latin America Digital Therapeutics Market Poised for Transformation as Healthcare Embraces Digital Solutions | Welldoc, Omada Health, Livongo, Noom, and DarioHealth | DataM Intelligence
Latin America Digital Therapeutics Market Poised for Transformation as Healthcar …
The Latin America digital therapeutics market is witnessing significant expansion, fueled by the region's growing burden of diabetes and cardiovascular diseases alongside increasing government and private sector initiatives to adopt digital health solutions. This growth is further accelerated by improving smartphone penetration and a shift towards value-based care models that prioritise patient outcomes and cost-effective management of chronic conditions. Get a Free Sample PDF Of This Report (Get Higher Priority for

All 5 Releases


More Releases for North

Man and Van North London: Your Go-To Moving Solution in North London
North London, London - June 23, 2025 - Looking for a stress-free and efficient moving experience in North London? Look no further than Man and Van North London, the trusted, reliable moving service that's changing the way people approach relocation. Based in the heart of North London at 2 Abbotsbury, the team at Man and Van North London provides affordable, hassle-free moving services designed to fit every need. Whether you're moving
North America Biosimulation Market
The global biosimulation market is experiencing rapid expansion, driven by advancements in technology and the increasing demand for computational tools that can accelerate drug discovery, clinical trials, and regulatory processes. As of 2023, the market was valued at USD 3.5 billion and is projected to reach USD 14.1 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 16.90% from 2024 to 2032. Biosimulation, which involves the use of
Entirewire Electrician North Canton Offers Top-Tier Electrical Services for Nort …
Image: https://www.getnews.info/wp-content/uploads/2024/09/1726505467.png Entirewire Electrician North Canton provides high-quality electrical services to residential and commercial clients in North Canton, OH. Specializing in electrical panel replacement, repairs, and installations, their team of certified electricians ensures safe, reliable, and efficient solutions, making them a trusted choice for all electrical needs in the local community. North Canton, OH - Entirewire Electrician North Canton continues to provide exceptional electrical services for residents and businesses in the
Web Design North: Providing Exceptional Graphic Design Services in North Bay
Web Design North, a leading digital marketing and SEO agency, provides peerless graphic design services in North Bay. Specific and highly effective digital solutions can help solve the challenges businesses encounter in reaching their target audience. With the combination of these solutions and the expertise of digital professionals, business owners can rest assured that they will make more progress and thrive among their competitors. Web Design North is a dedicated marketing
Web Design North Offers Digital Marketing Services in North Bay, Canada
Web Design North is a reputable company that provides digital marketing solutions and website development services in Canada. Web Design North is excited to debut its updated website, showcasing a more modern and user-friendly design. The new site features easy navigation, allowing potential clients to easily browse and learn about the company's services and view their impressive portfolio of work. As a leading web design company, Web Design North understands the
Web Design North Now Offers North Bay Website Designing Services
Web Design North has successfully worked with businesses of all sizes across North America and internationally. Web Design North, a leading digital marketing agency in Canada, is proud to announce its expertise in web designing and SEO marketing for businesses in various industries across the country. With a team of experienced professionals, Web Design North has helped numerous clients establish a strong online presence and drive significant traffic to their websites.